Shore Capital Partners Sale of Home Infusion Therapy Portfolio Company

We represented Shore Capital Partners in the sale of its home infusion therapy portfolio company, SCP Specialty Infusion, to AxelaCare Health Solutions. Shore Capital Partners is a healthcare-focused, Chicago-based private equity firm. From 2009 to 2011 Shore Capital completed three add-on acquisitions, one of which was the acquisition of Sirona Infusion, LLC, to found SCP Specialty Infusion, and built three de novo pharmacies to become one of the largest privately-owned home infusion platforms.

Shore Capital Partners is a healthcare-focused, Chicago-based private equity firm.

You Also May Be Interested In:

  • Served as fund formation counsel for the formation, capitalization, closing and operation of Brown Robin Partners’ current fund.

    We served as fund formation counsel for the formation, capitalization, closing and operation of Brown Robin Partners’ current fund.
  • Representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be acquired by funds managed by Stone Point Capital, with over $40 billion of assets under management; under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion

    We are representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be...
    Client Type: Public Company
  • Representation of Groups360, a leading platform for booking group travel, in its $35,000,000 investment from  Zigg Capital, Blackstone Innovations Investments, and Fir Tree Partners to accelerate growth.

    We represented Groups360, a leading platform for booking group travel, in its $35,000,000 investment from Zigg Capital, Blackstone Innovations Investments,...